Moderna says Covid-19 vaccine also generates antibodies among elderly
26th Aug 2020 16:56
(Sharecast News) - Moderna shares found a bid in the middle of the week after the biotechnology outfit announced that its experimental Covid-19 vaccine did generate antibodies against the disease in elderly patients.
Read moreOxford Covid-19 vaccine could be put before regulators this year
25th Aug 2020 08:22
(Sharecast News) - An experimental Covid-10 vaccine being developed by the University of Oxford and AstraZeneca could be put before regulators in 2020, the director of the Oxford Vaccine Group said on Tuesday.
Read moreFauci warns against premature EUA for Covid-19 vaccines
25th Aug 2020 07:51
(Sharecast News) - America's top health official warned of the risks of applying political pressure on the Food and Drug Administration to extend emergency use authorisation for its Covid-9 vaccine candidate before the November presidential elections in the US.
Read moreAstraZeneca starts trial of Covid-19 antibody treatment
25th Aug 2020 07:01
(Sharecast News) - AstraZeneca said the UK first participants have been dosed in a Phase I trial of a combination of two monoclonal antibodies (mAbs) to prevent and treat Covid-19.
Read moreSector movers: M&A speculation still in the driver's seat, Big Pharma gains
24th Aug 2020 15:23
(Sharecast News) - Mergers and acquisitions speculation continued to drive sector moves at the start of the week - yet again.
Read moreEurope open: 'Mini' trade deal, US Covid-19 treatment boost stocks
24th Aug 2020 12:13
(Sharecast News) - Stocks began the week with solid gains as investors cheered news that US health regulators had cleared the use of a potentially key treatment for Covid-19, convalescent plasma.
Read moreAstraZeneca rallies as Trump said to consider fast-tracking Covid vaccine
24th Aug 2020 11:46
(Sharecast News) - AstraZeneca shares rallied on Monday after it emerged that US President Donald Trump is considering fast-tracking an experimental Covid-19 vaccine being developed by the pharmaceuticals giant and Oxford University.
Read moreGoldman Sachs thinks markets underpricing odds for Covid-19 vaccine before year end
6th Aug 2020 15:23
(Sharecast News) - Goldman Sachs thinks the world will be in a very different place in three months' time on at least three front, so much so that investors' expectations for the outcomes will likely set the tone for trading until then.
Read moreAstraZeneca prices $3bn, three-tranche bond offering
4th Aug 2020 11:11
(Sharecast News) - AstraZeneca has priced a three-tranche global bond offering totalling $3bn (£2.3bn), it announced on Tuesday, to possibly repay its current debt.
Read moreRedx Pharma surges on AstraZeneca licensing agreement
4th Aug 2020 08:45
(Sharecast News) - Redx Pharma shares soared on Tuesday after it signed a licensing agreement with AstraZeneca for its porcupine inhibitor for fibrotic diseases, RXC006.
Read moreWHO warns 'silver bullet' for Covid-19 may never come
3rd Aug 2020 13:01
(Sharecast News) - The World Health Organization warned on Monday that there is a possibility that a "silver bullet" to combat Covid-19 may never come despite the existing strong hopes for a vaccine.
Read moreEurope midday: Losses accelerate as investors fret over epidemic's path
30th Jul 2020 10:44
(Sharecast News) - Losses in stockmarkets across Europe accelerated as investors digested data showing that German gross domestic product fell at its quickest pace on record since at least 1970.
Read moreAstraZeneca maintains guidance after first-half growth
30th Jul 2020 07:27
(Sharecast News) - AstraZeneca reported a 12% rise in total revenue in its first half on Thursday, or 14% at constant exchange rates, to $12.63bn (£9.75bn), with growth across all three of its therapy areas and in all of its regions.
Read moreThursday preview: US tech titans, AstraZeneca in focus
29th Jul 2020 16:19
(Sharecast News) - The market spotlight will fall on earnings reports from several of the largest corporates in the States, as they update shareholders on their performance over the three months to June, including Amazon, Alphabet, Facebook, and Microsoft.
Read moreWednesday broker round-up
29th Jul 2020 13:29
(Sharecast News) - Sanne: RBC Capital Markets reiterates sector performer with a target price of 600.0p.
Read more